Skip to main content
. Author manuscript; available in PMC: 2018 May 1.
Published in final edited form as: Clin Nucl Med. 2017 May;42(5):341–347. doi: 10.1097/RLU.0000000000001577

Table 2.

Relation of clinical and imaging variables to molecular tumor markers. For EGFR and MGMT promoter methylation, mean values in positive vs. negative subgroups are listed; the P value refers to the Mann-Whitney U test. For Ki-67 labeling, correlation coefficients (Spearman’s) and related P values are listed. Statistically significant values (P<.05) are in bold.

Variables EGFR MGMT Ki-67
Positive Negative P
value
Positive Negative P
value
r
value
P
value
Age (years) 64 62 0.8 67 59 0.1 0.21 0.4
Performance
status
83 82 0.6 86 80 0.9 0.07 0.8
Survival (days) 651 506 0.2 746 493 0.4 0.2 0.3
T1-Gad volume
(cm3)
6 21.3 0.04 11.7 16.1 0.5 −0.58 0.005
T2 volume (cm3) 36.4 44.8 0.9 48.8 40.9 0.1 −0.1 0.6
T1/T2 volume 0.14 0.52 0.04 0.19 0.49 0.2 −0.47 0.03
PET volume
(cm3)
52.7 41.3 0.6 23.2 48.3 0.045 −0.2 0.5
T1/PET volume 0.14 0.56 0.02 0.51 0.34 0.9 −0.5 0.02
PET SUV-ratio 2.4 2.1 0.2 2 2.3 0.3 0.04 0.9
PET VD-ratio 3.6 2.4 0.1 2.8 2.8 0.7 0.1 0.7
PET K-ratio 1.7 1.9 0.7 1.3 2 0.009 −0.1 0.7

Abbreviation: PET= positron emission tomography, EGFR= epidermal growth factor receptor, MGMT=O6-methylguanine-DNA methyltransferase, SUV= standardized uptake value, VD= volume of distribution, T1-Gad= post-contrast T1